S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jacek Pinski, MD
University of Southern California
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
123 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Regional Medical Center
Anniston, Alabama, United States
- Highlands Oncology Group - Springdale
Springdale, Arkansas, United States
- Alta Bates Summit Comprehensive Cancer Center
Berkeley, California, United States
- Peninsula Medical Center
Burlingame, California, United States
- Glendale Memorial Hospital Comprehensive Cancer Center
Glendale, California, United States
- Marin Cancer Institute at Marin General Hospital
Greenbrae, California, United States
- Sutter Health - Western Division Cancer Research Group
Greenbrae, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- University of California Davis Cancer Center
Sacramento, California, United States
- California Pacific Medical Center - California Campus
San Francisco, California, United States
- Sutter Solano Medical Center
Vallejo, California, United States
- Poudre Valley Hospital
Fort Collins, Colorado, United States
- M.D. Anderson Cancer Center at Orlando
Orlando, Florida, United States
- Veterans Affairs Medical Center - Hines
Hines, Illinois, United States
- Genesis Regional Cancer Center at Genesis Medical Center
Davenport, Iowa, United States
- Cancer Center of Kansas, Pa - Chanute
Chanute, Kansas, United States
- Cancer Center of Kansas, Pa - Dodge City
Dodge City, Kansas, United States
- Cancer Center of Kansas, Pa - El Dorado
El Dorado, Kansas, United States
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Kansas City, Kansas, United States
- Cancer Center of Kansas, Pa - Kingman
Kingman, Kansas, United States
- Southwest Medical Center
Liberal, Kansas, United States
- Cancer Center of Kansas, Pa - Newton
Newton, Kansas, United States
- Cancer Center of Kansas, Pa - Parsons
Parsons, Kansas, United States
- Cancer Center of Kansas, Pa - Pratt
Pratt, Kansas, United States
- Cancer Center of Kansas, Pa - Salina
Salina, Kansas, United States
- Cancer Center of Kansas, Pa - Wellington
Wellington, Kansas, United States
- Associates in Womens Health, Pa - North Review
Wichita, Kansas, United States
- Ccop - Wichita
Wichita, Kansas, United States
- Cancer Center of Kansas, Pa - Medical Arts Tower
Wichita, Kansas, United States
- Cancer Center of Kansas, Pa - Wichita
Wichita, Kansas, United States
- Via Christi Cancer Center at Via Christi Regional Medical Center
Wichita, Kansas, United States
- Cancer Center of Kansas, Pa - Winfield
Winfield, Kansas, United States
- Mary Bird Perkins Cancer Center - Baton Rouge
Baton Rouge, Louisiana, United States
- Pennington Cancer Center at Baton Rouge General
Baton Rouge, Louisiana, United States
- Mbccop - Lsu Health Sciences Center
New Orleans, Louisiana, United States
- Medical Center of Louisiana - New Orleans
New Orleans, Louisiana, United States
- Ccop - Michigan Cancer Research Consortium
Ann Arbor, Michigan, United States
- Saint Joseph Mercy Cancer Center
Ann Arbor, Michigan, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Battle Creek Health System Cancer Care Center
Battle Creek, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2007
- Primary completion
- 31 May 2009
- Completion
- 31 Jul 2011
- Last update posted
- 5 Feb 2013
- Registered enrollment
- 62
- Registry id
- NCT00433446
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.